[go: up one dir, main page]

MX2018007514A - Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden. - Google Patents

Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.

Info

Publication number
MX2018007514A
MX2018007514A MX2018007514A MX2018007514A MX2018007514A MX 2018007514 A MX2018007514 A MX 2018007514A MX 2018007514 A MX2018007514 A MX 2018007514A MX 2018007514 A MX2018007514 A MX 2018007514A MX 2018007514 A MX2018007514 A MX 2018007514A
Authority
MX
Mexico
Prior art keywords
compositions
assets
stabilized
preparing products
products
Prior art date
Application number
MX2018007514A
Other languages
English (en)
Inventor
Sai Ying Ko
Original Assignee
Biolingus Ip Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biolingus Ip Llc filed Critical Biolingus Ip Llc
Publication of MX2018007514A publication Critical patent/MX2018007514A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/02—Making microcapsules or microballoons
    • B01J13/04—Making microcapsules or microballoons by physical processes, e.g. drying, spraying
    • B01J13/043—Drying and spraying
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K40/00—Shaping or working-up of animal feeding-stuffs
    • A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00—Shaping or working of foodstuffs characterised by the products
    • A23P10/30—Encapsulation of particles, e.g. foodstuff additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/193—Colony stimulating factors [CSF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D—PROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00—Processes for applying liquids or other fluent materials
    • B05D1/02—Processes for applying liquids or other fluent materials performed by spraying

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Dispersion Chemistry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a un proceso para preparar un producto que comprende exenatida, caracterizado porque el proceso que comprende: (i) proporcionar un líquido de revestimiento que comprende exenatida, un sacárido y un disolvente miscible en agua; (ii) proporcionar partículas que comprende uno o más compuestos formadores de gel solubles en agua; (iii) fluidizar las partículas dentro de una cámara de procesamiento de un aparato de forma tal que las partículas se muevan en u na dirección ascendente dentro de la cámara en trayectoria helicoidal; (iv) pulverizar el líquido de revestimiento en las partículas para proporcionar partículas revestidas; y (v) permitir que las partículas revestidas se sequen.
MX2018007514A 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden. MX2018007514A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/AU2011/000173 WO2012109694A1 (en) 2011-02-18 2011-02-18 Process for preparing products comprising stabilised actives and compositions comprising same

Publications (1)

Publication Number Publication Date
MX2018007514A true MX2018007514A (es) 2022-10-21

Family

ID=46671860

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018007514A MX2018007514A (es) 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX2013009531A MX359670B (es) 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2013009531A MX359670B (es) 2011-02-18 2011-02-18 Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.

Country Status (13)

Country Link
US (2) US8951566B2 (es)
EP (2) EP3381299B1 (es)
JP (1) JP5793578B2 (es)
KR (1) KR101796340B1 (es)
CN (1) CN102791151B (es)
AU (1) AU2011323059B2 (es)
BR (1) BR112013020841B8 (es)
CA (1) CA2827432C (es)
DK (1) DK2675301T3 (es)
ES (1) ES2832973T3 (es)
MX (2) MX2018007514A (es)
RU (1) RU2563685C2 (es)
WO (1) WO2012109694A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102791151B (zh) * 2011-02-18 2016-01-20 高世英 制备包含稳定活性物的产品和包含相同活性物的组合物的方法
MY177940A (en) 2012-11-13 2020-09-28 Invictus Biotechnology Pty Ltd Transmucosal delivery of tocotrienol
WO2015170286A2 (en) 2014-05-08 2015-11-12 Biolingus Ip Llc Modulation of blood glucose levels
CN104920339B (zh) * 2015-06-04 2017-11-03 天津大学 利用生物相容性颗粒保存细胞的方法
JP6169137B2 (ja) * 2015-08-07 2017-07-26 バイオリンガス アイピー エルエルシー 安定化された活性物質含有の生成物の調製方法、および同生成物含有の組成物
EP3368010B1 (en) * 2015-10-26 2025-12-10 Blaesi, Aron H. Solid dosage form immediate drug release and apparatus and method for manufacture thereof
PL3962455T3 (pl) 2020-05-18 2023-01-16 Orexo Ab Nowa kompozycja farmaceutyczna do dostarczania leku
CN113084188B (zh) * 2021-04-06 2022-03-29 北京理工大学 一种多功能治疗性生物材料及其制备方法
IL313016A (en) 2021-11-25 2024-07-01 Orexo Ab A pharmaceutical preparation that includes adrenaline
GB202117016D0 (en) 2021-11-25 2022-01-12 Orexo Ab New pharmaceutical device

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4949299B1 (es) 1968-09-09 1974-12-26
DK125813B (da) 1971-04-16 1973-05-07 Niro Atomizer As Apparat til tørring af fugtige pulvere.
DE3690101T1 (es) 1985-03-01 1987-04-23
GB2177616B (en) * 1985-07-09 1988-07-06 Smidth & Co As F L Gas suspension reactor
SU1720678A1 (ru) * 1990-05-17 1992-03-23 Рубежанский филиал Днепропетровского химико-технологического института им.Ф.Э.Дзержинского Массотеплообменный аппарат
US5601760A (en) 1994-09-01 1997-02-11 The Regents Of The University Of California, A California Corporation Milk derived whey protein-based microencapsulating agents and a method of use
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets
AR021347A1 (es) * 1999-10-20 2002-07-17 Cipla Ltd Una composicion farmaceutica que contiene acido(s) bisfosfoncio o sal(es) del mismo y un proceso de preparacion de la misma
AUPR272901A0 (en) * 2001-01-25 2001-02-22 Gainful Plan Limited Method of preparing biological materials and preparations produced using same
ES2235642B2 (es) 2003-12-18 2006-03-01 Gat Formulation Gmbh Proceso de multi-microencapsulacion continuo para la mejora de la estabilidad y almacenamiento de ingredientes biologicamente activos.
US20060210614A1 (en) * 2003-12-26 2006-09-21 Nastech Pharmaceutical Company Inc. Method of treatment of a metabolic disease using intranasal administration of exendin peptide
GB2418382A (en) * 2004-09-24 2006-03-29 Mortimer Tech Holdings Particle treatment in an expanded toroidal bed reactor
US20090238885A1 (en) * 2006-05-22 2009-09-24 Nizo Food Research B.V. Protein encapsulated particles
EP2217088A1 (en) * 2007-11-29 2010-08-18 NIZO Food Research B.V. Method for making protein-based encapsulates
WO2009080024A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising an incretin mimetic
WO2009080032A1 (en) * 2007-12-20 2009-07-02 Fertin Pharma A/S Compressed chewing gum comprising a systemically active small peptide
CN101844053B (zh) * 2010-05-10 2013-06-12 重庆佳玛机械制造有限公司 一种旋流式流化床包衣机
US9795576B2 (en) * 2010-09-27 2017-10-24 Basf Se Protective coatings for acidic active ingredients
CN102791151B (zh) * 2011-02-18 2016-01-20 高世英 制备包含稳定活性物的产品和包含相同活性物的组合物的方法

Also Published As

Publication number Publication date
BR112013020841B8 (pt) 2021-11-30
BR112013020841A2 (pt) 2016-08-02
AU2011323059B2 (en) 2013-02-21
JP2014508750A (ja) 2014-04-10
RU2563685C2 (ru) 2015-09-20
JP5793578B2 (ja) 2015-10-14
EP2675301A1 (en) 2013-12-25
WO2012109694A1 (en) 2012-08-23
BR112013020841B1 (pt) 2021-10-26
CA2827432C (en) 2020-02-18
US20120219624A1 (en) 2012-08-30
KR20140037822A (ko) 2014-03-27
EP2675301B1 (en) 2018-12-12
US20150342886A1 (en) 2015-12-03
AU2011323059A1 (en) 2012-09-06
DK2675301T3 (en) 2019-03-25
KR101796340B1 (ko) 2017-11-10
EP3381299A1 (en) 2018-10-03
MX2013009531A (es) 2014-03-26
EP2675301A4 (en) 2015-07-15
RU2013140974A (ru) 2015-03-27
US8951566B2 (en) 2015-02-10
CA2827432A1 (en) 2012-08-23
MX359670B (es) 2018-10-05
US10369539B2 (en) 2019-08-06
ES2832973T3 (es) 2021-06-11
CN102791151A (zh) 2012-11-21
CN102791151B (zh) 2016-01-20
EP3381299B1 (en) 2020-08-19

Similar Documents

Publication Publication Date Title
MX2018007514A (es) Proceso para preparar productos que comprenden activos estabilizados y composiciones que los comprenden.
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
MD4589B1 (ro) Compoziţie farmaceutică cu conţinut de sofosbuvir şi utilizarea acesteia în tratamentul hepatitei virale C
ZA201208198B (en) Picolinamide and pyrimidine-4-carboxamine compounds, process for preparing and pharmaceutical composition comprising the same
PH12013500981A1 (en) Process for the preparation of a ppi-containing pharmaceutical product
ZA201108291B (en) Protein product and process for preparing injectable protein product
IT1401480B1 (it) Processo per la preparazione di prodotti cosmetici a tasselli in polvere o colati.
IN2015DN01061A (es)
MX2014000829A (es) Particulas que comprenden un principio activo a base de poliacrilato.
AP2014007399A0 (en) Phenyl-3-AZA-bicycloÄ3.1.0Ühex-3-YL-methanones andthe use thereof as medicament
PL2770827T3 (pl) Kompozycja, sposób otrzymywania kompozycji i zawierająca ją formulacja fitosanitarna
IN2015DN00924A (es)
PH12013501859A1 (en) Indolecarboxamides and benzimidazolecarboxamides as insecticides and acaricides
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
MX357284B (es) Compuestos de quinona para tratar enfermedades mediadas por ape1.
IN2014KN00892A (es)
MX2014004210A (es) Derivados de 2-oxo-piperidinilo.
GB201114962D0 (en) Composition, process and product
IN2014KN00893A (es)
CA143913S (en) Packaging for products
PL2763528T3 (pl) Preparat pestycydowy i proces jego wytwarzania
PH12014500080A1 (en) Active formulation for use in feed products
MX2013007014A (es) Metodo para la produccion de oxindoles sustituidos en el n con sulfonilo.
MX349563B (es) Formulacion farmaceutica de fenofibrato nanonizado.
MX384529B (es) Producto cosmetico con propiedades reparadoras del adn.